The cost of treating osteoporotic fractures in the United Kingdom female population - The author replies

被引:0
|
作者
Torgerson, DJ [1 ]
Dolan, P
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] Univ Sheffield, Sheffield Hlth Econ Grp, Sheffield, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:551 / 552
页数:2
相关论文
共 46 条
  • [21] The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population -Based Cohort Study
    Abtahi, Shahab
    Burden, Andrea M.
    Geusens, Piet
    van den Bergh, Joop P.
    van Staa, Tjeerd
    de Vries, Frank
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (06) : 811 - 816
  • [22] THE COST-EFFECTIVENESS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) FOR TREATING ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA IN THE UNITED KINGDOM
    Walton, M.
    Claxton, L.
    Sharif-Hurst, S.
    Wade, R.
    Eastwood, A.
    Hodgson, R.
    VALUE IN HEALTH, 2020, 23 : S406 - S406
  • [23] THE COST OF EPILEPSY IN THE UNITED-KINGDOM - AN ESTIMATION BASED ON THE RESULTS OF 2 POPULATION-BASED STUDIES
    COCKERELL, OC
    HART, YM
    SANDER, JWAS
    SHORVON, SD
    EPILEPSY RESEARCH, 1994, 18 (03) : 249 - 260
  • [24] Is peginterferon alfa-2b plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom?
    Wong, JB
    Rosenberg, WM
    Manns, MP
    McHutchison, JG
    Davis, GL
    Albrecht, JK
    Group, IHIT
    JOURNAL OF HEPATOLOGY, 2003, 38 : 181 - 181
  • [25] Economic Evaluation of Zoledronic Acid for the Prevention of Osteoporotic Fractures in Post-Menopausal Women with Early Breast Cancer Receiving Aromatase Inhibitors in the United Kingdom
    Logman, F.
    Heeg, B.
    Botteman, M.
    Kaura, S.
    van Hout, B.
    CANCER RESEARCH, 2009, 69 (24) : 574S - 574S
  • [26] The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom
    Claxton, Lindsay
    Walton, Matthew
    Sharif-Hurst, Sahar
    Wade, Ros
    Eastwood, Alison
    Hodgson, Robert
    VALUE IN HEALTH, 2022, 25 (05) : 787 - 795
  • [27] Prevalence of female urinary incontinence and its impact on quality of life in a cluster population in the United Kingdom (UK): a community survey
    Cooper, Jason
    Annappa, Manjula
    Quigley, Angela
    Dracocardos, Davina
    Bondili, Anu
    Mallen, Christian
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2015, 16 (04): : 377 - 382
  • [28] Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in post-menopausal women with early-stage breast cancer receiving aromatase inhibitors in the United Kingdom
    Logman, J. F. S.
    Heeg, B. M. S.
    Botteman, M. F.
    Kaura, S.
    van Hout, B. A.
    EJC SUPPLEMENTS, 2008, 6 (07): : 69 - 70
  • [29] Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam
    Steven J. Edwards
    Sarah Wordsworth
    Mike J. Clarke
    The European Journal of Health Economics, 2012, 13 : 181 - 192
  • [30] Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
    Taylor, Douglas C. A.
    Pandya, Ankur
    Thompson, David
    Chu, Paula
    Graff, Jennifer
    Shepherd, James
    Wenger, Nanette
    Greten, Heiner
    Carmena, Rafael
    Drummond, Michael
    Weinstein, Milton C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (03): : 255 - 265